CLINICAL FOCUS SESSION:
Detection and Characterization of Cancer in the Abdomen

Room 204 A/B
14:00 – 16:00

Chairs: Donald G. Mitchell, Keynote Speaker, and Richard Semelka

14:00 Keynote.
14:15 62. MR Imaging in Staging of Advanced Gastric Cancer: Is it Useful as Compared with Spiral CT? A.Y. Kim, C.K. Sung, T.K. Kim, J.K. Han and B.I. Choi, Seoul National University College of Medicine, Seoul, Korea.
14:27 63. Performance of Unenhanced MRI, SPIO-enhanced MRI, and Spiral-CT for the Detection and Characterization of Focal Hepatic Lesions: Results of a ROC-study with Multiple Observers, P. Reimer, N. Jähnke, M. Fiebich, C. Marx, F. Deckers, N. Holzknecht, W. Schima and S. Saini, Westfalian Wilhelms-University, Münster, Germany.
14:39 64. Double Contrast MRI for the Detection and Characterisation of Hepatocellular Carcinoma in the Cirrhotic Liver, J. Ward, J. Scott, J.A. Guthrie, D. Wilson and P.J. Robinson, St James's University Hospital, Leeds, UK.
14.51 65. Comparison of Contrast for MnDPDP Enhanced MR Imaging and Biphasic CE-CT of the Liver, P. van Dijk, R.H. Kruyt, P.E. Sijens and M. Oudkerk, University Hospital, Rotterdam, The Netherlands.
15:03 66. Early Homogeneously Enhancing Hemangioma versus Hepatocellular Carcinoma: Differentiation using Quantitative Analysis of Multiphasic Dynamic Contrast-Enhanced Magnetic Resonance Imaging, M-G. Jeong, J-S. Yu, K.W. Kim, B-J. Jo and J.K. Kim, Yonsei University College of Medicine, Seoul, South Korea.
15:15 67. MR Imaging of Hepatocellular Carcinoma (HCC): Prospective Evaluation with Explant Correlation, G. Krinsky, N. Theise, N.M. Rofsky, V.S. Lee, H. Mizrachi and J. Weinreb, New York University Medical Center, New York, NY, USA.
15:27 68. Comparative Diagnostic Accuracy of Magnetic Resonance Imaging and Positron Emission Tomography in the Detection of Liver Metastases in Patients with Malignant Melanoma, C. Altehoefer, N. Ghanem, S. Högerle, E. Nitzsche and M. Langer, University Hospital, Freiburg, Germany.
15:39 69. Preoperative MRI-Staging of Patients with Pancreatic Cancer, E. Castillo, U. Fischer, B. Salamat, O. Horstmann and E. Grabbe, Georg-August-Universität, Göttingen, Germany.

Return to ISMRM program